Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2013-12-24

FDA Approved: ONDANSETRON — Supplemental Application (Hospira, Inc.)

View source ↗

Summary

FDA approved a supplemental application for ondansetron from Hospira, Inc., a generic product. The approval confirms the supplemental filing for this ondansetro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ondansetron (ondansetron)

Snippet

SUPPL AP for ONDANSETRON (ONDANSETRON)